Cargando…
Diagnostics in Waldenström’s macroglobulinemia: a consensus statement of the European Consortium for Waldenström’s Macroglobulinemia
The diagnosis of Waldenström’s macroglobulinemia (WM), an IgM-associated lymphoplasmacytic lymphoma, can be challenging due to the different forms of disease presentation. Furthermore, in recent years, WM has witnessed remarkable progress on the diagnostic front, as well as a deeper understanding of...
Autores principales: | Dogliotti, Irene, Jiménez, Cristina, Varettoni, Marzia, Talaulikar, Dipti, Bagratuni, Tina, Ferrante, Martina, Pérez, José, Drandi, Daniela, Puig, Noemí, Gilestro, Milena, García-Álvarez, María, Owen, Roger, Jurczak, Wojciech, Tedeschi, Alessandra, Leblond, Veronique, Kastritis, Efstathios, Kersten, Marie José, D’Sa, Shirley, Kaščák, Michal, Willenbacher, Wolfgang, Roccaro, Aldo M., Poulain, Stephanie, Morel, Pierre, Kyriakou, Charalampia, Fend, Falko, Vos, Josephine M. I., Dimopoulos, Meletios A., Buske, Christian, Ferrero, Simone, García-Sanz, Ramón |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898035/ https://www.ncbi.nlm.nih.gov/pubmed/36435884 http://dx.doi.org/10.1038/s41375-022-01762-3 |
Ejemplares similares
-
Managing Waldenström’s macroglobulinemia with BTK inhibitors
por: Buske, Christian, et al.
Publicado: (2022) -
How to manage Waldenstrom's macroglobulinemia
por: Buske, C, et al.
Publicado: (2013) -
Consensus Statement on the Management of Waldenström Macroglobulinemia Patients During the COVID-19 Pandemic
por: Talaulikar, Dipti, et al.
Publicado: (2020) -
Treatment options for relapsed Waldenström's Macroglobulinemia
por: Grunenberg, Alexander, et al.
Publicado: (2019) -
Bleeding Propensity in Waldenström Macroglobulinemia: Potential Causes and Evaluation
por: Brysland, Simone A., et al.
Publicado: (2022)